Pub. Date : 2020 Oct
PMID : 32634436
6 Functional Relationships(s)Download |
Sentence | Compound Name | Protein Name | Organism |
| 1 | Overexpression of ABCB1 and ABCG2 contributes to reduced efficacy of the PI3K/mTOR inhibitor samotolisib (LY3023414) in cancer cell lines. | LY3023414 | mechanistic target of rapamycin kinase | Homo sapiens |
| 2 | Overexpression of ABCB1 and ABCG2 contributes to reduced efficacy of the PI3K/mTOR inhibitor samotolisib (LY3023414) in cancer cell lines. | LY3023414 | mechanistic target of rapamycin kinase | Homo sapiens |
| 3 | LY3023414 (samotolisib) is a promising new dual inhibitor of phosphoinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR). | LY3023414 | mechanistic target of rapamycin kinase | Homo sapiens |
| 4 | LY3023414 (samotolisib) is a promising new dual inhibitor of phosphoinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR). | LY3023414 | mechanistic target of rapamycin kinase | Homo sapiens |
| 5 | LY3023414 (samotolisib) is a promising new dual inhibitor of phosphoinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR). | LY3023414 | mechanistic target of rapamycin kinase | Homo sapiens |
| 6 | LY3023414 (samotolisib) is a promising new dual inhibitor of phosphoinositide 3-kinase (PI3K) and mammalian target of rapamycin (mTOR). | LY3023414 | mechanistic target of rapamycin kinase | Homo sapiens |